Tests brain-computer interface arm therapy for chronic stroke recovery
Tests brain-signal robotic arm therapy against attention training in adults with chronic stroke.
Plain-language title generated from the registry record
Registry title: ANIMATOR - RehUP BCI Controlled Robotic Therapy vs. an Attention-based Control
Key facts
- Where
- Calgary, CanadaSee the site
- Phase
- Phase 2
Where in Canada
- Foothills HospitalCalgary, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Calgary
- Trial code
- NCT06538506
- Record updated
- 9 August 2024
- Original description
ANIMATOR aims to examine how BCI therapy vs. attention based control therapy can be used to treat people in the chronic phase of stroke with moderate to severe upper extremity impairment. This interventional trial has two phases: Pilot (10 consecutive days of intervention) and a Randomized Phase (24 sessions over 8 weeks).Read full original descriptionShow less
ANIMATOR - A Single-blind Randomized Controlled Trial of RehUP BCI Controlled Robotic Therapy vs. an Attention-based Control
ANIMATOR aims to examine how BCI therapy vs. attention based control therapy can be used to treat people in the chronic phase of stroke with moderate to severe upper extremity impairment. This interventional trial has two phases: Pilot (10 consecutive days of intervention) and a Randomized Phase (24 sessions over 8 weeks).
Inclusion: Stroke survivors, ≥ 6 months post-stroke with severe arm impairment; 18 years of age of older; Adequate language skills to be able to follow instructions; FM-UE score 30 or less at study entry (i.e., severe arm impairment and would likely not use the stroke-affected arm in daily activities); Modified Ashworth Score ≦ 2; Visual acuity 20/50 corrected (both eyes).
Exclusion: enrollment in concurrent interventional trial; have neurologic history in addition to stroke (injury or disease), eg. TBI, MS, dementia; major co-morbid illness making study completion unlikely; Potential participants will be excluded if they do not meet the requirements above, or:; contraindication to MRI (such as pacemaker, pregnancy, etc).